Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men

被引:7
作者
Skoglund, Per H. [1 ,3 ]
Hoijer, Jonas [2 ]
Arnlov, Johan [4 ,6 ]
Zethelius, Bjorn [5 ,7 ]
Svensson, Per [1 ,3 ]
机构
[1] Karolinska Inst, Dept Med Solna, Stockholm, Sweden
[2] Karolinska Inst, Inst Environm Med, Biostat Unit, S-10401 Stockholm, Sweden
[3] Karolinska Univ Hosp Solna, Dept Emergency Med, Stockholm, Sweden
[4] Uppsala Univ, Dept Med Sci, Cardiovasc Epidemiol, Uppsala, Sweden
[5] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden
[6] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden
[7] Med Prod Agcy, Uppsala, Sweden
关键词
aged; B-type natriuretic peptide; blood-brain barrier; blood pressure monitoring; ambulatory; C-reactive protein; cardiovascular diseases; cystatin c; longitudinal studies; CORONARY-HEART-DISEASE; CYSTATIN-C; RISK; PREDICTION; BIOMARKERS; EVENTS; EVOLUTION; SOCIETY;
D O I
10.1161/HYPERTENSIONAHA.115.05717
中图分类号
R6 [外科学];
学科分类号
100210 [外科学];
摘要
Improvement of risk prediction for atherosclerotic cardiovascular disease (ASCVD) is needed. Both ambulatory blood pressure (ABP) and biomarkers amino-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein and cystatin C improve risk prediction but they have not been evaluated in relation to each other. We analyzed whether NT-proBNP, high-sensitivity C-reactive protein, or cystatin C improved risk prediction beyond traditional ASCVD risk factors combined with 24-hour systolic BP (SBP). Secondary aim was to evaluate whether ABP improved risk prediction when compared with models with the biomarkers. We followed up 907 70-year-old men, free of baseline disease, for incident ASCVD defined as fatal or nonfatal myocardial infarction or fatal or nonfatal stroke for a median of 10 years. Cox regression was used to estimate the association between variables in the models and incident ASCVD. Biomarkers were added to a model containing both traditional risk factors and ABP and the models were compared on C-statistics and net reclassification improvement. Twenty-four hour SBP improved discrimination for incident ASCVD when compared with office SBP in a traditional risk factor model (area under the receiver-operating characteristic curve, +2.4%). NT-proBNP further improved reclassification (+18.7%-19.9%; P<0.01) when added to ABP models, whereas high-sensitivity C-reactive protein and cystatin C did not. Twenty-four hour SBP significantly improved net reclassification when added to a traditional risk factor model that included NT-proBNP. The combination of 24-hour SBP and NT-proBNP improved discrimination and net reclassification for incident ASCVD when compared with office SBP in elderly men. NT-proBNP, but not high-sensitivity C-reactive protein or cystatin C, improved risk prediction and discrimination when added to a model that included ABP.
引用
收藏
页码:681 / 686
页数:6
相关论文
共 27 条
[1]
Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases [J].
Battistoni, Allegra ;
Rubattu, Speranza ;
Volpe, Massimo .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 157 (02) :160-168
[2]
Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension [J].
Clement, DL ;
De Buyzere, ML ;
De Bacquer, DA ;
de Leeuw, PW ;
Duprez, DA ;
Fagard, RH ;
Gheeraert, PJ ;
Missault, LH ;
Braun, JJ ;
Six, RO ;
Van Der Niepen, P ;
O'Brien, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) :2407-2415
[3]
The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease [J].
deGoma, Emil M. ;
Knowles, Joshua W. ;
Angeli, Fabio ;
Budoff, Matthew J. ;
Rader, Daniel J. .
CARDIOLOGY IN REVIEW, 2012, 20 (03) :118-129
[4]
B-Type Natriuretic Peptides and Cardiovascular Risk Systematic Review and Meta-Analysis of 40 Prospective Studies [J].
Di Angelantonio, Emanuele ;
Chowdhury, Rajiv ;
Sarwar, Nadeem ;
Ray, Kausik K. ;
Gobin, Reeta ;
Saleheen, Danish ;
Thompson, Alexander ;
Gudnason, Vilmundur ;
Sattar, Naveed ;
Danesh, John .
CIRCULATION, 2009, 120 (22) :2177-U39
[5]
EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144
[6]
Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men [J].
Emberson, J. R. ;
Haynes, R. ;
Dasgupta, T. ;
Mafham, M. ;
Landray, M. J. ;
Baigent, C. ;
Clarke, R. .
JOURNAL OF INTERNAL MEDICINE, 2010, 268 (02) :145-154
[7]
Goff DC Jr, 2014, CIRCULATION, V129, pS49, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]
[8]
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[9]
2-4
[10]
Helmersson-Karlqvist J, 2012, INT J CLIN EXP MED, V5, P145